Kathleen Borthwick

CIK: 0001987062

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (28.6%)

Position reduction

Option Exercises (M)2 (28.6%)

Derivative conversions

Awards (A)3 (42.9%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PASG

Passage BIO, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

PASG
Passage BIO, Inc.
Mar 16, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
15.6K shares-
PASG
Passage BIO, Inc.
Jan 8, 2026
Sale(S)
Direct
2.1K shares at avg. $18.44$38K
PASG
Passage BIO, Inc.
Jan 8, 2026
Exercise(M)
Direct
5K shares-
PASG
Passage BIO, Inc.
Mar 15, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
278.4K shares-
PASG
Passage BIO, Inc.
Feb 11, 2025
Sale(S)
Direct
3.2K shares at avg. $0.53$2K
PASG
Passage BIO, Inc.
Feb 10, 2025
Exercise(M)
Direct
8K shares-
PASG
Passage BIO, Inc.
Jan 15, 2025
Award(A)
Restricted Stock Unit
Direct
10K shares-

		Type	Shares	Price		Ownership
Mar 16, 2026	PASG Passage BIO, Inc.	Award(A) Employee Stock Option (right to buy)	15,610	-	-	Direct
Jan 8, 2026	PASG Passage BIO, Inc.	Sale(S)	2,062	$18.44	$38,022	Direct
Jan 8, 2026	PASG Passage BIO, Inc.	Exercise(M)	5,000	-	$0	Direct
Mar 15, 2025	PASG Passage BIO, Inc.	Award(A) Employee Stock Option (right to buy)	278,386	-	-	Direct
Feb 11, 2025	PASG Passage BIO, Inc.	Sale(S)	3,183	$0.53	$1,686	Direct
Feb 10, 2025	PASG Passage BIO, Inc.	Exercise(M)	8,000	-	-	Direct
Jan 15, 2025	PASG Passage BIO, Inc.	Award(A) Restricted Stock Unit	10,000	-	-	Direct

1-7 of 7 transactions

About Borthwick Kathleen

Borthwick Kathleen (SEC CIK 0001987062) files insider reports with the SEC as CFO of Passage BIO, Inc. (PASG).

Signal8 holds 5 ownership filings by Borthwick Kathleen, all Form 4s, filed between Feb 12, 2025 and Mar 18, 2026. Those filings report 7 transactions, from Jan 15, 2025 to Mar 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Borthwick Kathleen's filings is in PHILADELPHIA, PA.

Recent filings by Borthwick Kathleen

Mar 16, 2026: Grant or award of PASG derivative securities (Form 4, code A).
Jan 8, 2026: Open-market sale of PASG shares (Form 4, code S).
Jan 8, 2026: Option exercise of PASG shares (Form 4, code M).
Mar 15, 2025: Grant or award of PASG derivative securities (Form 4, code A).
Feb 11, 2025: Open-market sale of PASG shares (Form 4, code S).

Other insiders filing for Passage BIO, Inc. (PASG)

How to read Form 4 transaction codes